[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

MX9707695A - Empaque que contiene una formulacion de solucion acuosa de clorhidrato de procaterol, y una formulacion de solucion acuosa de clorhidrato de procaterol. - Google Patents

Empaque que contiene una formulacion de solucion acuosa de clorhidrato de procaterol, y una formulacion de solucion acuosa de clorhidrato de procaterol.

Info

Publication number
MX9707695A
MX9707695A MX9707695A MX9707695A MX9707695A MX 9707695 A MX9707695 A MX 9707695A MX 9707695 A MX9707695 A MX 9707695A MX 9707695 A MX9707695 A MX 9707695A MX 9707695 A MX9707695 A MX 9707695A
Authority
MX
Mexico
Prior art keywords
aqueous solution
procaterol hydrochloride
solution formulation
hydrochloride aqueous
package holding
Prior art date
Application number
MX9707695A
Other languages
English (en)
Inventor
Yuzo Kimura
Shinichi Ishikawa
Masafumi Toda
Takakuni Matsuda
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Publication of MX9707695A publication Critical patent/MX9707695A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4704—2-Quinolinones, e.g. carbostyril

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)

Abstract

Un objeto de la presente invencion es impartir estabilidad de almacenamiento a largo plazo a una composicion farmacéutica que comprende una solucion acuosa de clorhidrato de procaterol. Esta invencion está dirigida a una solucion acuosa de clorhidrato de procaterol que asegura que el clorhidrato de procaterol se proteja de ser descompuesto en la solucion acuosa debido a su reaccion de oxidacion.
MX9707695A 1995-04-04 1996-03-25 Empaque que contiene una formulacion de solucion acuosa de clorhidrato de procaterol, y una formulacion de solucion acuosa de clorhidrato de procaterol. MX9707695A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP7856495 1995-04-04
PCT/JP1996/000772 WO1996031195A1 (en) 1995-04-04 1996-03-25 Package holding a procaterol hydrochloride aqueous solution formulation, and a procaterol hydrochloride aqueous solution formulation

Publications (1)

Publication Number Publication Date
MX9707695A true MX9707695A (es) 1997-12-31

Family

ID=13665401

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9707695A MX9707695A (es) 1995-04-04 1996-03-25 Empaque que contiene una formulacion de solucion acuosa de clorhidrato de procaterol, y una formulacion de solucion acuosa de clorhidrato de procaterol.

Country Status (7)

Country Link
EP (1) EP0820274A1 (es)
KR (1) KR19980703582A (es)
AR (1) AR002981A1 (es)
AU (1) AU5015296A (es)
CA (1) CA2217360A1 (es)
MX (1) MX9707695A (es)
WO (1) WO1996031195A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004530644A (ja) * 2000-12-21 2004-10-07 アルコン、インコーポレイテッド コンタクトレンズとの併用に適した人工涙組成物
US9636355B2 (en) 2011-09-22 2017-05-02 Theo Holdings, Llc Hypertonic dextran solution and methods of treating and preventing recurrent corneal erosion
SMT201900525T1 (it) * 2014-05-07 2019-11-13 Croma Pharma Ges M B H Soluzione oftalmica acquosa e metodo per rattare la sindrome dell’occhio secco
US10744088B2 (en) 2015-10-06 2020-08-18 G-Treebnt Co., Ltd. Method for preparing ophthalmic preparation containing thymosin beta-4
RU2743274C9 (ru) * 2015-11-10 2021-04-08 Общество с ограниченной ответственностью "ДИАМЕД-фарма" Фармацевтический препарат для лечения артрологических заболеваний
RU2612019C1 (ru) * 2015-12-11 2017-03-01 Общество с ограниченной ответственностью "ДИАМЕД-фарма" Способ производства инъекционной формы препарата на основе хондроитина сульфата
CN114159398B (zh) * 2021-03-22 2023-05-23 南京艾德加生物制药科技有限公司 一种盐酸丙卡特罗口服固体组合物及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2638156B2 (ja) * 1988-11-11 1997-08-06 優樹 小田切 薬剤組成物
JP3390477B2 (ja) * 1993-01-25 2003-03-24 生化学工業株式会社 薬剤組成物及びその製造法

Also Published As

Publication number Publication date
AR002981A1 (es) 1998-05-27
WO1996031195A1 (en) 1996-10-10
CA2217360A1 (en) 1996-10-10
EP0820274A1 (en) 1998-01-28
KR19980703582A (ko) 1998-11-05
AU5015296A (en) 1996-10-23

Similar Documents

Publication Publication Date Title
HK1042444A1 (zh) 藥用噴霧製劑
US6136294C1 (en) Amino acid stabilized medical aerosol formulation
ES2097546T3 (es) Preparaciones cosmeticas desodorantes que contienen esteres di- o trigliceridos.
IL114449A0 (en) Multiple unit tableted dosage form
CO5580776A2 (es) Formulacion farmaceutica estable en solucion de oxaliplatino
DK0717617T3 (da) Mikropartikler indeholdende aktive bestanddele og gas
MXPA03000442A (es) Una formulacion medicinal en aerosol.
GEP20022709B (en) Pharmaceutical Compositions Having Appetite Suppressant Activity
EP0251369A3 (en) Pharmaceutical compositions endowed with sequestering activity for the biliary acids, containing colestyramin as their active principle, and process for preparing them
TW229208B (es)
WO2001041737A3 (en) Solid oral dosage form
YU211087A (en) Process for obtaining new n-substituted benzimidazolic derivatives
PL346764A1 (en) New oral formulation for 5-ht4
AP2003002716A0 (en) Medicinal compositions containing propenone derivatives.
BR9707551A (pt) Composições contendo um antifúngico e um composto de enxofre.
MX9700470A (es) Uso de triacetato de glicerilo para tratar onicomicosis.
HUP0102369A3 (en) Amino acid derivatives and drugs containing the same as the active ingredient
MX9504023A (es) Composicion farmaceutica y transdermicamente activa que contiene acido 5-aminolaevulinico y procedimiento para su preparacion.
MX9707695A (es) Empaque que contiene una formulacion de solucion acuosa de clorhidrato de procaterol, y una formulacion de solucion acuosa de clorhidrato de procaterol.
GB9505082D0 (en) Medicament
LT96094A (en) The active ingredient of pharmaceutical composition for treating constipation
DE59205998D1 (de) Arzneimittel mit antineoplastischer Wirkung enthaltend als Wirkstoff Octadecyl-[2-(N-methylpiperidino)-ethyl]-phosphat und Verfahren zu dessen Herstellung
PT1150660E (pt) Formulacao farmaceutica efervescente contendo metamizole
DK8291D0 (da) Praeparat omfattende en aktiv bestanddel, fortrinsvis i pulver- eller partikelform, samt en baerer for den aktive bestanddel og fremgangsmaade til fremstilling af et saadant praeparat
HUP9800078A2 (hu) Gyógyászati készítmény, amely hatóanyagként jódot és ezüstnitrátot tartalmazó etanolos oldatból áll, és eljárás előállítására